Antihypertensive efficacy of the angiotensin II AT1-receptor antagonist losartan: results of a randomized, double-blind, placebo-controlled, parallel-group trial using 24-hour blood pressure monitoring. Ambulatory Blood Pressure Monitoring Study Gro
(Q71769007)
scientific article published on 01 January 1996
scientific article published on 01 January 1996
Language: